You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
16 February 2026 - Medicine company Eli Lilly and Company (NYSE: LLY) on Monday reported positive topline data from the Phase 3 LIBRETTO-432 trial evaluating Retevmo (selpercatinib) as adjuvant therapy in patients with stage II–IIIA RET fusion-...
16 February 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Monday that a universal respiratory syncytial virus immunisation programme using Beyfortus (nirsevimab) was associated with a statistically signifi...
16 February 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), on Monday reported positive Phase III results from the MAJESTY study evaluating Gazyva (obinutuzumab) in adults with primary membranous nep...
16 February 2026 - Medical technology company Advita Ortho announced on Friday that it has updated Chime, its clinical exchange application designed to help orthopaedic surgeons connect, collaborate and share clinical insight.Available exclusively to...
16 February 2026 - Coreline Soft, a South Korea-based medical AI company specialising in thoracic imaging, announced on Saturday that it is collaborating with INFINITT North America, a developer of enterprise imaging solutions, to bridge the gap betw...
16 February 2026 - HanchorBio Inc (TPEx:7827), a global clinical-stage biotechnology company based in Taiwan, announced on Friday that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for HCB101 for the tre...